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The atherogenic and carcinogenic effects of
arsenic have long been observed among indi-
viduals exposed to a high level of inorganic
arsenic from drinking artesian well water in
the villages located at the southwestern coast
of Taiwan (1). 
In our recent study, the prevalence of
diabetes mellitus was 2-fold higher in these
areas than in Taipei City and the Taiwan
area in general (2). A dose–response relation
between cumulative arsenic exposure (CAE)
and the prevalence of diabetes mellitus was
also demonstrated after adjustment for mul-
tiple risk factors (2). Rahman and Axelson
(3) carried out a small case–control study on
Swedish copper smelter workers; using the
death records for 1960–1976 from the
parish register, they compared three arsenic
exposure categories with an unexposed
group. They observed an increased risk of
dying from diabetes mellitus with increasing
arsenic exposure; odds ratios were 2.0, 4.2,
and 7.0 (p = 0.03 for the trend) for exposure
to < 0.5, 0.5, and > 0.5 mg/m3 arsenic in the
air, respectively, as compared to an unex-
posed control group. In another similar but
larger study carried out among art glass
workers, the odds ratio of dying from dia-
betes mellitus was 1.8 [95% confidence
interval (CI), 1.1–2.8] for the exposed glass
workers as compared to the unexposed ones
(4). In a community-based survey of dia-
betes mellitus in Bangladesh, Rahman et al.
(5) observed a dose–response trend between
the prevalence of diabetes mellitus and the
arsenic level in drinking water. 
Prevalence data provide the information
for the generation of hypotheses, but suffer
from some drawbacks in evaluating a causal
relationship. Because the prevalence of a
given disease is a function of its incidence
and duration (6), an increase of prevalence
could be attributable to the increase in dis-
ease incidence and/or duration. If long-term
arsenic exposure increases the incidence and
decreases the survivalship of diabetes melli-
tus, the dose–response manner between
arsenic and diabetes mellitus will be less strik-
ing when prevalence is used rather than inci-
dence data. Therefore, it is more appropriate
to look further into the association between
long-term arsenic exposure and the incidence
of diabetes mellitus. In this paper, we
describe our study in which we used a bian-
nual 75 g oral glucose tolerance test to follow
a cohort of subjects who were free from dia-
betes mellitus for a period of 4 years. 
Materials and Methods
The study area, study subjects, original com-
munity-based survey, and estimation of CAE
have been previously described in detail (2).
In brief, the study area included three villages
located on the southwestern coast of Taiwan
where arseniasis was hyperendemic. Because
of the high salinity in the water of shallow
wells, residents in these villages used artesian
well water for drinking and cooking (7). The
median arsenic concentration of artesian well
water ranged from 0.70 to 0.93 mg/L (7,8).
A tap water supply system using surface water
was implemented in the 1960s, but few peo-
ple had access to this water until the late
1970s. The standard for arsenic in drinking
water set by the U.S. Environmental
Protection Agency is 0.05 mg/L (9). 
In Taiwan, the household registration sys-
tem is effective and efﬁcient because of the
completeness and accuracy of the registration
information. To recruit a cohort of residents
for a long-term follow-up study on health
hazards associated with long-term arsenic
exposure, we selected only those residents
who lived at least 5 days a week in the study
villages. A total of 2,258 residents older than
30 years of age were registered in the study
villages, but only 1,571 of them were eligible
for the recruitment in our cohort. Most of the
other 687 registered residents worked in
Chiayi City and its suburban area, returning
to the study villages during weekends. All eli-
gible subjects were interviewed at home from
September 1988 through June 1989. A stan-
dardized personal interview based on a struc-
tured questionnaire was carried out by two
public health nurses who were well trained in
interview techniques and questionnaire details.
Information obtained from the interviews
included history of high-arsenic artesian well
water consumption, residential history, socioe-
conomic and demographic characteristics,
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Articles
Diabetes prevalence in arseniasis-hyperendemic villages in Taiwan has been reported to be signiﬁ-
cantly higher than in the general population. The aim of this cohort study was to further evaluate
the association between ingested inorganic arsenic and the incidence of non–insulin-dependent
diabetes mellitus in these villages. A total of 446 nondiabetic residents in these villages were fol-
lowed biannually by oral glucose tolerance test. Diabetes is deﬁned as a fasting plasma glucose
level ≥ 7.8 mmol/L and/or a 2-hr post-load glucose level ≥ 11.1 mmol/L. During the follow-up
period of 1499.5 person-years, 41 cases developed diabetes, showing an overall incidence of
27.4/1,000 person-years. The incidence of diabetes correlated with age, body mass index, and
cumulative arsenic exposure. The multivariate-adjusted relative risks were 1.6, 2.3, and 2.1 for
age ≥ 55 versus < 55 years, a body mass index ≥ 25 versus < 25 kg/m2, and a cumulative arsenic
exposure ≥ 17 versus < 17 mg/L-years, respectively. The incidence density ratios (95% conﬁdence
intervals) between the hyperendemic villages and the two nonendemic control townships were 3.6
(3.5–3.6), 2.3 (1.1–4.9), 4.3 (2.4–7.7), and 5.5 (2.2–13.5), respectively, for the age groups of
35–44, 45–54, 55–64, and 65–74 years. The ﬁndings are consistent with our previous cross-sec-
tional observation that ingested inorganic arsenic is diabetogenic in human beings. Key words:
diabetes mellitus, incidence, ingested arsenic, oral glucose tolerance test, water pollutant. Environ
Health Perspect 108:847–851 (2000). [Online 31 July 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p847-851tseng/abstract.htmlalcohol intake, cigarette smoking, physical
activities, as well as a personal and family
history of hypertension and diabetes. A total
of 1,081 eligible subjects interviewed
between September and December 1988
were invited to participate in a health exami-
nation in January and February 1989 on a
voluntary basis. No incentives were offered
to the subjects. Another 490 eligible subjects
who were interviewed after December 1988
were not invited to participate in the exami-
nation. A total of 941 residents, including
408 men and 533 women, participated in
the community-based health examination
from January to February 1989. Among
them, 381 (93.4%) men and 510 (95.7%)
women agreed to be tested for diabetes mel-
litus by oral glucose tolerance test. Lai et al.
(2) analyzed these data and found that the
prevalence of diabetes mellitus was signifi-
cantly associated with CAE. To further clari-
fy the diabetogenic effect of arsenic, we
decided to follow the subjects who were not
found to be diabetic and whose CAE data
were available in the prevalence study for the
development of diabetes mellitus. After
exclusion of known cases of diabetes mellitus
identiﬁed during the baseline health exami-
nation (86 cases) and residents whose CAE
status was unknown (173 cases), a total of
632 subjects were eligible for the evaluation
of the association between the incidence of
diabetes mellitus and CAE. In 1991 and
1993, 446 of them agreed to participate in
the follow-up examination by oral glucose
tolerance test.
Some study subjects had moved from
one village to another, and the arsenic con-
centrations were different in the artesian well
water of these villages. We derived an index
of CAE to reflect the overall exposure to
arsenic for each study subject, taking into
account both the duration and the arsenic
level of artesian well water. This CAE index
is the sum of products derived by multiply-
ing the arsenic concentration in well water
(in milligrams per liter) by the duration of
water consumption (in years) during consec-
utive periods of residence in different 
villages. Thus, the CAE is derived by the fol-
lowing formula: Σ (Ci × Di), where Ci is the
median arsenic concentration in the well
water of the village where a given study sub-
ject lived during period i, and Di is the dura-
tion of drinking well water in the village
during period i. We calculated cumulative
arsenic exposure only for subjects for whom
there was complete information on arsenic
exposure from drinking water throughout
the subject’s lifetime. In other words, the
arsenic exposure index of a given subject was
classiﬁed as unknown if the arsenic concen-
tration of well water in any village where the
subject had lived during his or her lifetime
was not available. We excluded the subjects
with unknown CAEs from the follow-up
study of diabetes incidence.
For the determination of fasting plasma
glucose, we collected blood samples in the
morning after overnight fasting for > 12 hr.
We then conducted an oral glucose tolerance
test by administering 75 g glucose dissolved in
300 mL water. Post-load blood samples were
taken 2 hr after the glucose loading. Plasma
glucose levels were determined on-site with a
glucose analyzer (LM4 analyzer; Analox
Instruments Ltd., London, UK) using a glu-
cose oxidase method. We deﬁne diabetes mel-
litus as a fasting glucose level ≥ 7.8 mmol/L
and/or a 2-hr post-load glucose level ≥ 11.1
mmol/L according to the criteria set by the
World Health Organization (WHO).
We recorded the follow-up person-time
for each individual and calculated diabetes
incidence under the assumption that diabetes
mellitus is a lifelong disease. We calculated
the overall incidence rate of diabetes mellitus
in the study population as the total number of
incident cases divided by the sum of follow-
up person-time in all subjects. The incidence
rate in speciﬁc subgroups of age, sex, body
mass index (BMI), and CAE was calculated as
the number of newly diagnosed cases divided
by the sum of person-time of individuals in
the subgroup. To clarify the effect of arsenic
exposure on the incidence of diabetes mellitus
adjusting for age, sex, and BMI, we compared
the incidences between the lower and higher
arsenic exposure groups at different strata of
these possible confounders.
For control areas, we used two nonen-
demic townships for which incidence of
non–insulin-dependent diabetes mellitus
(NIDDM or Type 2) was recently reported
(10). We used this published data for ecolog-
ic comparison because the two populations
(endemic and nonendemic areas) shared
many similarities. The study areas are all
rural areas in Taiwan. Most of the residents
in these areas are engaged in farming, ﬁshery,
and salt production. All of the subjects are of
the same racial origin (Fukkien Taiwanese)
and share similar socioeconomic status, living
environments, lifestyles, dietary patterns,
medical facilities, and educational levels. The
only major differences in environmental
exposure among residents in the arseniasis-
hyperendemic area appears to be the arsenic
level in the drinking water. Moreover, our
cohort study shares many similarities in
method and analysis with the study of Wang
et al. (10). Both studies were carried out dur-
ing similar study periods by using the WHO
criteria for diagnosis of diabetes mellitus. The
calculation and expression of incidences of
diabetes mellitus were similarly based on an
incidence density method by calculating the
person-years of follow-up of each of the study
subject. Moreover, similar confounders such
as age, sex, and BMI were all considered in
both studies. The values of these variables
were also available for making comparisons.
To compare our data with those of Wang et
al. (10), we calculated the age-speciﬁc inci-
dences of diabetes mellitus for the arseniasis-
hyperendemic villages by categorizing the
subjects into age groups similar to those used
by Wang et al. (10) in the control areas. We
also calculated the incidence density ratios
between the arseniasis-hyperendemic villages
and the control areas. 
We used the chi-square test and the
Student’s t-test to compare the differences in
the baseline data between the subjects who
were followed-up successfully and those who
were lost to follow-up in our cohort,
between our cohort and the external control
cohort by Wang et al. (10), and between the
incident and nonincident cases in our
cohort. We used multivariate analysis by
Cox’s proportional hazards model to esti-
mate the relative risks of higher arsenic expo-
sure on the incidence of diabetes mellitus
after adjustment for the effects of age, sex,
and BMI. We calculated the 95% CIs of the
relative risks from the corresponding regres-
sion coefﬁcients and standard errors. 
Results
During a follow-up period of 1499.5 person-
years, 41 of 446 subjects developed diabetes
mellitus in the arseniasis-hyperendemic vil-
lages. The calculated incidence rate was
27.4/1,000 person-years. The follow-up rate
was 70.6%. Table 1 shows a comparison of
the baseline characteristics between subjects
who were followed-up successfully and those
who were lost to follow-up in the arseniasis-
hyperendemic villages. None of these vari-
ables differed signiﬁcantly between these two
groups. In univariate analyses, we found no
signiﬁcant associations with incidence of dia-
betes mellitus for variables such as sex, ciga-
rette smoking, alcohol consumption, physical
activity at work, and family history of diabetes
mellitus. However, age and BMI were signiﬁ-
cantly associated with diabetes incidence.
Table 2 presents the comparison of the
baseline characteristics in subjects followed-up
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Table 1. Comparison of baseline characteristics
between subjects who were followed-up suc-
cessfully and those who were lost to follow-up in
arseniasis-hyperendemic villages.
Followed-up Lost
Variables (n = 446) (n = 186)
Age (years) 47.4 ± 0.5 47.5 ± 0.9
Sex (% male) 50% 54.3%
Body mass index (kg/m2) 24.5 ± 0.2 23.9 ± 0.3
CAE 12.1 ± 0.5 13.2 ± 0.8
Values shown are mean ± SE except where indicated.
Differences are not signiﬁcant for any of the variables or
on the basis of chi-square test or Student’s t-test. successfully between the arseniasis-hyperen-
demic group and the nonendemic external
control group. The BMI was not signiﬁcantly
different between the two groups. However,
our arsenic-exposed cohort was younger with
an equal number of men and women, and the
control group was older and had more
women. Because sex was not found to be a
signiﬁcant risk factor for newly developed dia-
betes mellitus in both our current study and
the study by Wang et al. (10) and the BMI
was similar between the two comparison
groups, only age could exert signiﬁcant con-
founding effect when the incidence rates in
these two groups are compared. We further
stratiﬁed age into subgroups and compared
the age-specific incidence density ratios in
each subgroup. The age-speciﬁc incidences of
diabetes mellitus in the arseniasis-hyperen-
demic villages and the two nonendemic con-
trol townships are shown in Figure 1. The
age-specific incidence density ratios (95%
CIs) between the hyperendemic villages and
control townships were 3.6 (3.5–3.6), 2.3
(1.1–4.9), 4.3 (2.4–7.7), and 5.5 (2.2–13.5),
respectively, for the age groups of 35–44,
45–54, 55–64, and 65–74 years. The subjects
living in arseniasis-hyperendemic villages have
higher incidence rates of diabetes mellitus
than subjects living in nonendemic areas. 
The baseline data of the newly diagnosed
diabetic and nondiabetic subjects living in
arseniasis-hyperendemic villages are shown
in Table 3. The distribution of sex was not
significantly different between these two
groups. However, newly diagnosed diabetic
cases had a significantly higher mean age,
BMI, and CAE than nondiabetic subjects.
We used cutoff points to categorize various
continuous variables. We used a BMI cutoff
of 25 kg/m2 because it is generally used to
deﬁne overweight (11). We did not use the
definition of obesity (BMI ≥ 30 kg/m2)
because in the Taiwanese population, only a
small proportion of diabetic patients met
this criterion. We used the age cutoff of 55
years because there was an abrupt increase in
the incidence of diabetes mellitus in the age
cohort > 55 years of age at the time of
recruitment, as shown in Figure 1. We used
the CAE cutoff of 17 mg/L-years, the medi-
an value of CAE in the newly diagnosed
cases, in order to obtain optimal numbers in
each subgroup of exposure to assure precise
estimates for the relative risks.
Table 4 shows the comparison of the
incidence rates of diabetes mellitus between
groups of CAE < 17 and ≥ 17 mg/L-years by
different strata of age, sex, and BMI.
Subjects with a CAE ≥ 17 mg/L-years con-
sistently had a higher incidence rate of dia-
betes mellitus than those with a CAE < 17
mg/L-years.
Table 5 shows a comparison of the inci-
dence rates and relative risks between differ-
ent subgroups of age, sex, BMI, and CAE.
Age, BMI, and CAE were signiﬁcantly associ-
ated with the development of diabetes. The
multivariate-adjusted relative risks (95% CIs)
based on the Cox’s proportional hazards
model were 1.6 (0.8–3.3), 1.1 (0.6–2.1), 2.3
(1.2–4.3), and 2.1 (1.1–4.2), respectively, for
groups of old age, male sex, overweight, and
high CAE compared with groups of young
age, female sex, normal weight, and low
CAE. When used as a continuous variable,
the CAE was associated with incidence of
diabetes mellitus with a relative risk of 1.03
for every 1 mg/L-year of exposure after
adjustment for age, sex, and BMI (p < 0.05).
Discussion
The results of this study support the associa-
tion between a long-term arsenic exposure
and diabetes mellitus, as found in our previ-
ous prevalence study (2) and in the studies
observed by other investigators (3–5).
However, this is the ﬁrst prospective follow-
up study that assessed the incidence of dia-
betes mellitus in the arseniasis-hyperendemic
villages by comparing the data to data
obtained from two nonendemic control areas
(external control) (Figure 1) and by compar-
ing a higher arsenic exposure group to a lower
exposure group after adjustment for age, sex,
and BMI in the arseniasis-hyperendemic vil-
lages (internal control) (Tables 4 and 5). The
incidences rose abruptly in the age groups
> 55 years among villagers in arseniasis-hyper-
endemic area (Figure 1). These birth cohorts
also have an abrupt increase in the prevalence
of peripheral vascular disease assessed with
Doppler ultrasonography (12). They had
higher long-term arsenic exposures than those
< 55 years of age. They were exposed to well
water for > 30 years, which was deemed to be
an induction period for blackfoot disease
(BFD) before tap water became commonly
accessible. BFD is an endemic peripheral vas-
cular disease confined to the southwestern
coast of Taiwan. It is characterized by pro-
gressive narrowing of peripheral arteries, espe-
cially those involving the lower extremities.
Clinically, the patients suffer from coldness,
numbness, and intermittent claudication in
the lower legs, which may progress to ulcera-
tion, gangrene, and spontaneous amputation
(12,13). Pathologically, BFD is compatible
with thromboangiitis obliterans and arte-
riosclerosis obliterans (12,13). The cause of
the disease has been ascribed to the drinking
of artesian well water containing high arsenic
concentrations (12,13). 
Age and BMI are known risk factors for
the development of diabetes mellitus (10,14).
We also observed this association in the pre-
sent study. However, the diabetes incidence
for the higher arsenic exposure group (CAE
≥ 17 mg/L-years) remained 2 times higher
after multivariate adjustment (Table 5). In the
comparison between the higher arsenic expo-
sure group (≥ 17 mg/L-years) and the lower
exposure group (< 17 mg/L-years) in our
cohort, the relative risk for the high exposure
group would have been underestimated
because a large proportion of the referent
group had also been exposed to arsenic. They
were not in a group with truly low exposure
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Table 2. Comparison of baseline characteristics in
subjects who were followed-up successfully
between the arseniasis-hyperendemic group and
the nonendemic control group.
Arseniasis- Nonendemic 
Variables hyperendemic control pa
Age (years) 47.4 ± 0.5 52.3 ± 0.5 < 0.005
Sex (% male) 50% 45.4 % < 0.005
BMI (kg/m2) 24.5 ± 0.1 24.2 ± 0.2 NS
NS, not signiﬁcant. Values shown are mean ± SE except
where indicated. 
aBased on chi-square test or Student’s t-test. 
Figure 1. Comparison of age-specific incidence
rates (per 1,000 person-years) of diabetes mellitus
in arseniasis-hyperendemic villages and in two




















































Nonendemic townships Table 3. Comparison of baseline characteristics between newly diagnosed diabetic and nondiabetic sub-
jects living in arseniasis-hyperendemic villages in Taiwan.
Newly diagnosed  Noncases
Variables cases (n = 41) (n = 405) pa
Sex (% male) 58.5 49.1 NS
Age (% ≥ 55 years) 36.6 18.5 < 0.01
BMI (% ≥ 25 kg/m2) 58.5 36.3 < 0.01
CAE (% ≥ 17 mg/L-years) 51.2 27.4 < 0.005
Age (years) 52.7 ± 1.6b 46.8 ± 0.5 < 0.001
BMI (kg/m2) 25.8 ± 0.7 24.3 ± 0.2 < 0.05
CAE (mg/L-years) 15.6 ± 1.7 11.8 ± 0.5 < 0.05
NS, not signiﬁcant. 
aBased on chi-square test or Student’s t-test. bMean ± SE. levels. This can be supported in part by the
observation that the age-specific incidence
density ratios between the arseniasis-hyperen-
demic group and the external control group
without arsenic exposure had a risk > 2 times
higher (Figure 1). According to the continu-
ous data analysis, a CAE difference of 50
mg/L-years will result in a relative risk of 4.4.
We observed NIDDM because all of the
study subjects were > 30 years of age. None
of them developed diabetic ketoacidosis or
required insulin treatment during the period
of follow-up. Moreover, all of the subjects
were diagnosed by an oral glucose tolerance
test without signiﬁcant clinical symptoms. 
There are only a few reports on the inci-
dence of NIDDM. According to the study
of Bender et al. (15) in Minnesota, the inci-
dence rate of NIDDM in Caucasians is
1.2/1,000 person-years. In Nauruans, the
incidence rate is 16.0/1,000 person-years in
subjects > 20 years of age (16), and in Pima
Indians, the incidence rate is 18.5/1,000
person-years for all ages combined and
46/1,000 person-years in subjects > 25 of
age (17). After standardization to the white
population in the United States in 1970, the
incidence rates of NIDDM are 1.34/1,000
and 26.5/1,000 person-years for Caucasians
and Pima Indians, respectively (17). Wang
et al. (10) followed a cohort for up to 5
years; this cohort, from two townships in
Taiwan, was 35–74 years of age and free
from diabetes. The crude incidence rates 
of NIDDM in men and women were
9.8/1,000 and 9.0/1,000 person-years,
respectively. After age-standardization to the
United States population in 1970, the inci-
dence rate was calculated to be 9.3/1,000
person-years. In our present study carried
out in a cohort with arsenic exposure, the
incidence of diabetes mellitus standardized
to the United States population in 1970 was
approximately 2 times higher than that in
the nonendemic areas. 
The administration of arsenic has been
demonstrated to cause hyperglycemia in
experimental animals and to affect the func-
tions of insulin receptor and glucose trans-
portation (18–24). Arsenic has been found to
cause mitochondrial damage, degeneration,
and necrosis of β cells in the islets of mice
after intraperitoneal injection of arsenite plus
hydroxylamine, with a consequence of tran-
sient hyperglycemia (18). Sulfhydryl groups
play important structural and functional roles
in both insulin receptors (25) and glucose
transporters (26). Phenylarsine oxide, a triva-
lent arsenical, forms stable cyclic thioarsenite
complexes with vicinal or paired thio groups
of cellular proteins. This compound has been
shown to inhibit glucose transport in
adipocytes stimulated by the insulin mimick-
ers vanadate and hydrogen peroxide (22).
Phenylarsine oxide has also been shown to
inhibit protein internalization, and it exhibits
an inhibitory effect on the internalization of
insulin receptor complexes in rat hepatocytes
(27) and CT3-C2 ﬁbroblasts (28). Jhun et al.
(29) demonstrated the existence of a pheny-
larsine oxide sensitive GLUT4 degradation in
rat adipocytes, which might have pathophysi-
ologic significance, giving rise to clinical
problems of insulin resistance. Phenylarsine
oxide also inhibits the stereospeciﬁc uptake of
D-glucose in basal and insulin-stimulated rat
adipocytes (19–22) in a dose–response pat-
tern. Phenylarsine oxide also inhibits insulin
binding at a higher concentration and insulin
internalization (19). Douen and Jones (19)
suggested that phenylarsine oxide has a direct
inhibitory effect on both the receptor system
and the transporter system, possibly by react-
ing with sulfhydryl groups at or near the
receptor or transporter sites. This does not
exclude the possibility of a reaction with a
component of the coupling system between
receptor and transporter, as suggested by
Frost and Lane (22).
Vicinal sulfhydryls also play important
roles in the activation of glucose transport by
insulin and insulin-like agents in skeletal
muscle (24). Phenylarsine oxide exhibits an
inhibitory effect on insulin-stimulated or
hypoxia-stimulated glucose transport in rat
skeletal muscle (24). Denervation-induced
postreceptor resistance of glucose transport
to insulin and insulin-like growth factor I
also involves primarily a phenylarsine oxide-
sensitive pathway in rat skeletal muscle (23).
Deficiencies of trace elements such as
copper and zinc have been suggested to play
some role in the pathogenesis of diabetes
mellitus (30). On the other hand, adminis-
tration of cadmium has been shown to cause
hyperglycemia (31). Arsenic has been report-
ed to interact with these chemicals. Arsenic
exposure can lead to a signiﬁcant increase in
renal copper excretion and can potentiate the
effects of cadmium when arsenic and cadmi-
um are used together (32). Arsenic may also
compete with zinc in metal-binding proteins
that display vicinal dithiols contained in zinc
ﬁngers of DNA binding and repair proteins.
This competitive binding causes conforma-
tional change and altered biologic function in
proteins (33). These effects of arsenic may
explain some of the possible mechanisms of
its diabetogenic effect.
In conclusion, the diabetogenic effect of
arsenic in humans has been reported in differ-
ent ethnic groups via different exposure routes
(2–5). To the best of our knowledge, this is
the first study to evaluate the association
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Table 4. Incidence of diabetes mellitus (per 1,000 person-years) in low and high CAE groups in arseniasis-
hyperendemic villages in Taiwan.
CAE (mg/L-years)
< 17 ≥ 17
Newly diagnosed Incidence  Newly diagnosed Incidence 
Variable Total no. cases (n) rate Total  no. cases  (n) rate
Age (years)
≥ 55 28 2 21.1 62 13 64.8
< 55 286 18 18.8 70 8 33.3
Sex
Male 145 11 22.1 78 13 49.2
Female 169 9 16.1 54 8 45.2
BMI (kg/m2)
≥ 25 122 11 26.5 49 13 78.1
< 25 192 9 13.8 83 8 28.2
Table 5. Incidence rates (per 1,000 person-years) and relative risks for diabetes mellitus in subgroups of
subjects living in arseniasis-hyperendemic villages in Taiwan.
Newly diagnosed Incidence
Variable Total no. DM cases (n)  rate RR (95% CI) ARR (95% CI)
Age (years)
≥ 55 90 15 50.8 2.4 (1.3–4.5)* 1.6 (0.8–3.3)
< 55 356 26 21.6 1.0 1.0
Sex
Male 223 24 31.5 1.3 (0.7–2.5) 1.1 (0.6–2.1)
Female 223 17 23.1 1.0 1.0
BMI (kg/m2)
≥ 25 171 24 42.1 2.3 (1.2–4.3)* 2.3 (1.2–4.3)*
< 25 275 17 18.3 1.0 1.0
CAE (mg/L-years)
≥ 17 132 21 47.6 2.5 (1.4–4.7)* 2.1 (1.1–4.2)*
< 17 314 20 18.9 1.0 1.0
Abbreviations: DM, diabetes mellitus; RR, relative risk (based on Cox models with each variable singly); ARR, adjusted
relative risk (based on Cox model with all variables simultaneously).
* p < 0.05.between high arsenic exposure from drinking
water and the development of diabetes melli-
tus by following the incidence of diabetes in
a cohort exposed to arsenic. We also per-
formed an ecologic comparison by compar-
ing the incidences of diabetes mellitus in our
cohort and an external control population
studied by other investigators (10). Our ﬁnd-
ings support the hypothesis that arsenic is
diabetogenic in humans. Although the
pathophysiologic mechanisms of arsenic
require further investigation, the health haz-
ards of arsenic exposure should be attended
and remedial measures should be taken.
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